Data gathered: October 11
Alternative Data for Ocean Biomedical
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | N/A | Sign up | Sign up | Sign up |
| Sentiment | 93 | Sign up | Sign up | Sign up |
| Webpage traffic | 1,000 | Sign up | Sign up | Sign up |
| Google Trends | N/A | Sign up | Sign up | Sign up |
| Patents | N/A | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | N/A | Sign up | Sign up | Sign up |
| Facebook Followers | 235 | Sign up | Sign up | Sign up |
| Instagram Followers | 101 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 1 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 2,745 | Sign up | Sign up | Sign up |
| Twitter Followers | 264 | Sign up | Sign up | Sign up |
| Twitter Mentions | 21 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Linkedin Employees | 12 | Sign up | Sign up | Sign up |
About Ocean Biomedical
Ocean Biomedical is a new-generation American biopharmaceutical company based in Providence, Rhode Island. The company has product candidates addressing malaria, pulmonary fibrosis, and lung cancer.
| Price | $0.91 |
| Target Price | Sign up |
| Volume | 21,160 |
| Market Cap | $32M |
| Year Range | $0.53 - $5.56 |
| Dividend Yield | 0% |
| Analyst Rating | 0% buy |
| Industry | Biotechnology |
In the news
Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Publication of New Data Deepening Understanding of Novel Cancer Immunotherapy Treatment Approach Targeting CHI3L1 and its Ability to Inhibit Anti-tumor and Related Tissue Remodeling ResponsesOctober 1 - GlobeNewswire |
|
Ocean Biomedical's oncology platform included in new published studySeptember 30 - Thefly.com |
|
 |
Ocean Biomedical, Inc. (NASDAQ:OCEAW) Sees Large Decrease in Short InterestSeptember 26 - ETF Daily News |
 |
Ocean Biomedical: Dr. Jonathan Kurtis, MD issued patent for malaria treatmentAugust 27 - Thefly.com |
Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Patent Issued for PfGARP Malaria Antibodies Central to Company’s Malaria Treatment and Prevention PlatformsAugust 27 - GlobeNewswire |
|
Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Patent Issued for PfGARP Malaria Antibodies Central to Company?s Malaria Treatment and Prevention PlatformsAugust 26 - GlobeNewswire |
|
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '23 | 0 | 2.4M | -2.9M | -14M | -2.7M | -0.530 |
| Q2 '23 | 0 | 2.7M | -4.2M | -13M | -2.7M | -0.390 |
| Q1 '23 | 0 | 12M | -27M | -67M | -18M | 0.430 |
| Q4 '22 | 0 | 0 | 7.1M | 410,000 | -610,000 | 0.031 |
| Q3 '22 | 0 | 1.3M | -1.4M | -3.7M | -1.4M | -0.080 |
Insider Transactions View All
| AJJARAPU SURENDRA K filed to buy 5,411,000 shares at $1. March 2 '23 |
Similar companies
Read more about Ocean Biomedical (OCEA) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, news mentions, customer reviews & linkedin employees.
What is the Market Cap of Ocean Biomedical?
The Market Cap of Ocean Biomedical is $32M.
What is the current stock price of Ocean Biomedical?
Currently, the price of one share of Ocean Biomedical stock is $0.91.
How can I analyze the OCEA stock price chart for investment decisions?
The OCEA stock price chart above provides a comprehensive visual representation of Ocean Biomedical's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Ocean Biomedical shares. Our platform offers an up-to-date OCEA stock price chart, along with technical data analysis and alternative data insights.
Does OCEA offer dividends to its shareholders?
As of our latest update, Ocean Biomedical (OCEA) does not offer dividends to its shareholders. Investors interested in Ocean Biomedical should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Ocean Biomedical?
Some of the similar stocks of Ocean Biomedical are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.